Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
CLL Induction Treatment With Venetoclax and Ibrutinib, Followed by Ibrutinib and Obinutuzumab in Patients With MRD.B-cell chronic lymphocytic leukemiaActive, not recruitingPhase 22021-08-23NCT04639362

2 results · Page 1 of 1

Swipe the table sideways for more columns.

27 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
DK-Aalborg-AALBORGUHAalborgDenmark3
DK-Herlev-HERLEVHerlevDenmark1
DK-Odense-OUHOdenseDenmark5
DK-Roskilde-ROSKILDERoskildeDenmark2
NL-Almere-FlevoziekenhuisAlmere StadNetherlands4
NL-Amersfoort-MEANDERMCAmersfoortNetherlands13
NL-Amsterdam-AMCAmsterdamNetherlands10
NL-Amsterdam-VUMCAmsterdamNetherlands10
NL-Den Haag-HAGAThe HagueNetherlands13
NL-Den Haag-HMCWESTEINDEThe HagueNetherlands1
NL-Dordrecht-ASZDordrechtNetherlands14
NL-Ede-ZGVEdeNetherlands6
NL-Eindhoven-CATHARINAEindhovenNetherlands7
NL-Enschede-MSTEnschedeNetherlands11
NL-Gouda-GROENEHARTGoudaNetherlands1
NL-Groningen-UMCGGroningenNetherlands17
NL-Hilversum-TERGOOIHilversumNetherlands4
NL-Hoofddorp-SPAARNEGASTHUISHoofddorpNetherlands7
NL-Roermond-LZRRoermondNetherlands1
NL-Rotterdam-IKAZIARotterdamNetherlands4
NL-Sittard-Geleen-ZUYDERLANDSittardNetherlands5
NL-Sneek-ANTONIUSSNEEKSneekNetherlands3
NL-Terneuzen-ZORGSAAMTerneuzenNetherlands2
NL-Tilburg-ETZTilburgNetherlands5
NL-Uden-BERNHOVENUdenNetherlands2